Characteristic | Biologic group (n=30) | Nonbiologic group (n=30) | P-value |
---|
Type of surgery THA/TKA | 18 (60%)/12 (40%) | 18 (60%)/12 (40%) | – |
Gender, male/female | 3 (10%)/27 (90%) | 3 (10%)/27 (90%) | – |
Age, years | 50,5[27,3; 58,0] | 49,5[34,0; 56,0] | 0,773 |
Disease duration, years | 12,5[8,8; 19,0] | 12,5[8,0; 19,0] | 0,689 |
DAS28 | 4,2[3,2; 4,8] | 4,2[3,5; 5,1] | 0,240 |
Hb, g/l | 119,5[104; 133,5] | 121,5[113,0; 134,8] | 0,501 |
CRP, mg/l | 9,0[1,0; 28,1] | 9,5[0,8; 38,5] | 0,678 |
HAQ | 1,9[1,5; 2,3] | 1,9[1,4; 2,4] | 0,818 |
EQ-5D | 0,52[0,0; 0,52] | -0,02[-0,9; 0,52] | 0,041 |
NSAID, n (%) | 27 (90%) | 26 (86,7%) | 1,0 |
DMARDs, n (%) | 22 (73,3%) | 25 (83,3%) | 0,532 |
Methotrexate, n (%) | 17 (56,7%) | 21 (70,0%) | 0,671 |
Prednisone, n (%) | 23 (76,7%) | 18 (60,0%) | 0,267 |